论文信息 - Crystal and molecular structures of 1-(2-iso butylylcarbamoyl propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (1) (C21H31N2O3Cl) and 1-(2-isobutyloxycarbonylo propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (2) (C21H30NO4Cl) - 字舞流文

Crystal and molecular structures of 1-(2-iso butylylcarbamoyl propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (1) (C21H31N2O3Cl) and 1-(2-isobutyloxycarbonylo propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (2) (C21H30NO4Cl)

M. Wieczorek | G. Bujacz | E. Galas | A. Wojciechowska | J. Zjawiony

[1] H. T. Jones,et al. Synthesis of A575C, a combined angiotensin converting enzyme inhibitor-beta adrenoceptor antagonist , 1988 .

[2] J. Binet,et al. Synthesis of a series of compounds related to betaxolol, a new beta 1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases. , 1987, Journal of medicinal chemistry.

[3] J. Pitha,et al. Affinity labels for beta-adrenoceptors: preparation and properties of alkylating beta-blockers derived from indole. , 1987, Journal of medicinal chemistry.

[4] D. I. Stuart,et al. An empirical method for correcting diffractometer data for absorption effects , 1983 .

[5] H. Ammon,et al. The crystal structures of dichloroisoproterenol, propranolol and propranolol hydrochloride , 1977 .